Abstract
Abstract Background Whilst it has long been known that anti-vaccination sentiment is widely disseminated through digital networks, 2019 has seen seismic shifts in the landscape. As viral videos originating on Youtube spread across social networks, HPV vaccine uptake tumbled in a number of countries. In Japan, the government came under sufficient pressure that they de-recommended HPV vaccine, seeing a 70% uptake rate in 2013 fall below 1%. However, there have been some reports of successful interventions - a recent campaign run by the HPV Alliance in Ireland has seen a rate back up to a national average of around 75%. A combination of hard-hitting personal testimonials, social media and traditional media looked to promote the HPV vaccine. Methods Social media platforms such as Twitter enable near real-time understandings of vaccine sentiment and information flows at scale. VAC Medi+Board project developed an innovative approach for Twitter data collection, integration, analysis and visualisation to support rapid responses through identifying key influencers and flashpoints in articles about vaccination going viral. Results This pilot study evaluated the debate about HPV on Twitter in a period of several month and developed methods for analysis and visualisation of the content, key influencers, information diffusion throughout the network and size of audience. Through complex network analysis, VAC Medi+Board piloted identification of individuals for targeted public health interventions to combat misinformation. Conclusions In this talk, we will present the VAC Medi+Board HPV study and explore the challenges and opportunities that social media can provide for public health policymakers. Key messages Analysis and graphical visualisation of HPV debate on Twitter to support targeted public health interventions at real-time. Contributing to better understanding the role of social media in the complex picture of vaccines hesitancy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.